Basic Information
MEFRIL-250 CAPSULE 250 mg
CAPSULE
Regulatory Information
SIN10125P
October 2, 1998
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XM01AG01
Company Information
Active Ingredients
Strength: 250 mg
Detailed Information
Contraindications
**CONTRAINDICATIONS:** - Hypersensitivity to the active substance or any of the excipients - Inflammatory bowel disease. - History of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy. - Active or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding). - Severe heart failure, hepatic failure and renal failure. - History of hypersensitivity reaction to other NSAIDs. - During the last trimester of pregnancy. - Treatment of pain after coronary artery bypass graft (CABG) surgery.
Indication Information
**INDICATIONS AND USES:** Mefenamic acid capsules is used to relieve various types of pain such as: headache; body aches, rheumatoid arthritis, osteoarthritis; muscle and joint pains; toothache; sprains; painful menstruation (dysmenorrhea and menorrhagia); trauma-related pains.